Clinical Trial Update: Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating expanded autologous bone marrow mesenchymal cells in adults with established chronic spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Expanded autologous bone marrow mesenchymal cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Puerta de Hierro University Hospital | Conditions: Spinal Cord Injury | Phase 2 | Status: COMPLETED